Partner with the Leaders Building Medtech

Alex Jiao

CEO

Scout Health is bringing rapid molecular testing to the point-of-care. The Scout System packages similar technology to PCR lab-grade tests that normally require a clinic to be performed into a small hub and single-use tests. The system is currently approved for the testing of COVID, with additional tests for common illnesses in development.  Visit website.

Ash Attia

CEO

BVT Bionic Eye System is a suprachoroidal visual implant that has been designed to restore functional vision to the blind suffering from inherited retinal diseases. The Bionic Eye System consists of a retinal implant that receives visual images that are captured, processed, and transferred via a wearable device and processing unit.  Visit website.

James Lancaster

CEO

Solenic Medical is developing a non-invasive medical device that utilizes alternating magnetic fields to eradicate biofilms that form on implants. The company's platform uses external magnetic coils to destroy infective biofilms on the surface of knee and hip replacement implants, as well as plates and rods for trauma related procedures. Solenic's solution is being developed to replace the expensive and risky two-step revision surgery, which is the current standard of care for chronic infections on medical implants. Visit website.

Amrish Nair

Founder/Director

Femom is a comprehensive maternity care platform to improve perinatal outcomes through mobile technology and data science. Designed for in-home and hospital use, Femom's priority solution enables healthcare professionals to gain new insights to the health of the mother and fetus while offering more convenience and information. Visit website.

Lloyd Mencinger

President & CEO

Treating gastrointestinal disease with disruptive, vapor-based endoscopic ablation therapy. Visit website.

Malcolm Hebblewhite

President

The Atmo Gas Capsule is a unique ingestible capsule to provides unique insights into gut health and microbiome function. The device assesses the functional health of the GI system by means of measuring gaseous biomarkers as it passes through the GI system. Atmo Biosciences investigational device offers the potential to shed new light on disorders of the gut, beginning with highly prevalent motility disorders such as gastroparesis and slow transit constipation. Visit website.

Dr Shieak Tzeng

Co-founder & CEO

Wellumio is a venture-backed company specializing in portable MRI solutions for acute neuroimaging applications. The company’s core enabling technology is a novel pulse-gradient free nuclear magnetic resonance sensor platform with an initial focus on acute stroke triage and diagnosis. Visit website.

Caitlin Morse

CEO

BrainSpace is developing a solution to simplify critical care in neurocritical patients. BrainSpace is committed to improving the way brain pressure is managed in patients recovering from stroke, traumatic brain injury, and neurosurgery. Currently patients requiring intracranial pressure management must be meticulously monitored and measured hourly by a nurse. The company has developed an automated monitoring solution as an alternative to the antiquated drainage monitoring relying on a manometer-based drain and blood pressure monitor that eliminates the hassle for patients and providers while improving the quality of data being captured for researchers and physicians. Visit website.

Anastasia Rigas

CEO

Heteron's solution is a hand-held breath analyzer will screen and monitor for biomarkers of gastrointestinal and liver diseases. The technology is intended to replace existing diagnostic testing tools for point-of-care testing, ultimately allowing users to screen themselves and to monitor dietary and long-term medical interventions. Visit website.

Yossi Bar

CEO

LEM Surgical is focused on creating and providing the next generation of robotic surgical systems. The company's flagship product, the Dynamis System, is a multi-arm robotic surgical system that incorporates novel navigation capabilities and has an open architecture for handling concentric tools. Dynamis is intended to be a platform technology for orthopedic and neurosurgical applications. Visit website.

Solveig Johannessen

CEO

Satisfai Health is a software company focusing on computer vision AI for gastroenterology, across both endoscopic and ultrasound imaging. Our products are used by pharmaceutical companies and healthcare providers to digitally assess important, life-altering conditions, including Inflammatory Bowel Disease and pre-Esophageal Cancer. Visit website.

Christopher Haig

Co-Founder/Chief Executive Officer

Efemoral Medical is a clinical stage startup developing a next-generation drug-eluting bioresorbable scaffold for the treatment of PAD. Using a minimally invasive procedure, the Efemoral Vascular Scaffold System is inserted into the leg and expanded inside the artery to restore a channel for blood flow to the foot. The scaffold is strong enough to hold the vessel open, is flexible enough to accommodate the complex skeletal motion of the leg, and elutes a drug to prevent scarring inside the vessel which leads to the need for repeat procedures. The scaffold is naturally absorbed by the body over time, thus leaving behind no permanent implant. Visit website.

Justin Anderson

CEO

Tensor Surgical develops technologies for orthopedic soft tissue repair sports medicine. The company’s portfolio of products consists of solutions to simplify and reduce the cost rotator cuff repair and bicep tenodesis procedures.  Visit website.

Leo Smit

CEO

Hy2Care's vision is to support patients in the fight against osteoarthritis. The company's lead product, CartRevive, is a hydrogel implant composed of dextran and hyaluronic acid conjugates that form a resorbable scaffold when injected. The hydrogel enables natural restoration of tissue defects by creating an environment conducive to cell regrowth that proceeds towards the restoration of smooth hyaline cartilage.  Visit website.

Bora Chang

Founder & CEO

The annual cost of avoidable complications to the entire U.S. healthcare system is $45 billion. KelaHealth has developed a software-as-a-service (SaaS) solution designed to address this problem by accurately predicting who will develop surgical complications and connecting the patient's risks with evidence-based interventions, helping surgeons to adopt actions that prevent complications after surgery. The company's platform uses applied artificial intelligence and big data analytics, to accurately predict and build a personalized report for each patient, for each procedure. Visit website.

Dr Lynne Lim

Founder & CEO

NousQ is a Singapore medical device start up with the world’s first robotic handheld surgical applicator aiming to insert ear tubes with just one click, in one second. By moving surgery from the operating theatre/ general anesthesia setting to the clinic/ local anesthesia setting, over 100 million more patients with middle ear infection can be helped.  Visit website.

Rhodel Dacanay

Anesthesiologist/Inventor

The NEVENT Safety Sheath is a newly patented medical device that provides the only effective method of preventing the patient harm and medical system costs of retained guidewires after vascular catheter placement. Engineering out human error and providing safer care to our patients.

Peter Fischer

CEO

InkSpace Imaging pioneers a transformative printed electronics platform, initially prioritizing advanced MRI receive coils. These lightweight and flexible coils not only elevate diagnostic imaging, revealing the once invisible, but also expedite scans, enhance patient experiences, reduce the need for sedation, and minimize procedures. Compatible with existing MRI systems and healthcare reimbursement structures, the company's FDA-cleared innovation represents a next-generation approach to accessible, high-quality diagnostics. Visit website.

Xiang Li

CEO, Co-founder

The Surgical-Fiberlcok technology functions like a surgical “sewing” machine, mechanically “interlocking” the medical patch fibers into soft tissue, allowing the surgeon to attach patches in an easier, faster, and more reliable way for various clinical applications for soft-tissue repair and augmentation. The enabling device for this technology, called FiberLocker® System, received FDA clearance for rotator cuff reinforcement in December 2024. Visit website.

Jason Turner

CEO

Description coming soon. Visit website.

Carlos Granada

Co-Founder

LearUp is looking to accelerate clinical trial timelines. The only All-in-one Solution. Smart patient matching and data-driven platform that reduces clinical trial timelines without risking quality. Visit website.